# Tau-directed therapeutics

Source: https://onco.cc/technologies/da-tech-tau-therapeutics/  
OnCo record `da-tech-tau-therapeutics` (Technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Tau-directed treatments are in trials. None is an approved dementia medicine on this atlas.

## Summary

Because tau tracks clinical progression, it is a major pipeline theme. Benefit and safety remain trial questions.

## Fields

- Kind: Technology
- Status: emerging
- Last checked: 2026-09-21
- Tags: dementia-atlas
- Principle: Antisense, antibody, or small-molecule approaches aimed at tau protein.

## Sources

- ClinicalTrials.gov: https://clinicaltrials.gov

## Connected records

- fronts: [Anti-tau research](https://onco.cc/fronts/da-front-anti-tau/)
- targets: [Tau](https://onco.cc/targets/da-target-tau/)
- diagnoses: [Alzheimer’s disease](https://onco.cc/diagnoses/alzheimers-disease/)

---
JSON: https://onco.cc/api/v1/entities/da-tech-tau-therapeutics.json